CervoMed (CRVO) EPS (Basic) (2022 - 2025)
CervoMed (CRVO) has disclosed EPS (Basic) for 9 consecutive years, with -$0.88 as the latest value for Q4 2025.
- Quarterly EPS (Basic) fell 10.0% to -$0.88 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.98 through Dec 2025, down 46.8% year-over-year, with the annual reading at -$2.98 for FY2025, 47.52% down from the prior year.
- EPS (Basic) hit -$0.88 in Q4 2025 for CervoMed, down from -$0.84 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.65 in Q3 2023 to a low of -$2.95 in Q4 2022.
- Historically, EPS (Basic) has averaged -$1.13 across 4 years, with a median of -$0.86 in 2025.
- Biggest five-year swings in EPS (Basic): surged 138.24% in 2023 and later tumbled 184.62% in 2024.
- Year by year, EPS (Basic) stood at -$2.95 in 2022, then surged by 67.8% to -$0.95 in 2023, then grew by 15.79% to -$0.8 in 2024, then decreased by 10.0% to -$0.88 in 2025.
- Business Quant data shows EPS (Basic) for CRVO at -$0.88 in Q4 2025, -$0.84 in Q3 2025, and -$0.7 in Q2 2025.